- Page 2:
ILLUSTRATED DICTIONARY OF IMMUNOLOG
- Page 5 and 6:
CRC Press Taylor & Francis Group 60
- Page 8:
Preface The splendid reception of t
- Page 12 and 13:
Illustration Credits Figure for C1
- Page 14:
Figure for Sustiva ® (efavirenz ca
- Page 17 and 18:
α helix 2 αβ TCR checkpoint muco
- Page 19 and 20:
abzyme 4 accessory molecules Trypan
- Page 21 and 22:
acetaldehyde adduct autoantibodies
- Page 23 and 24:
acquired immunity 8 activated lymph
- Page 25 and 26:
acute cellular rejection 10 acute d
- Page 27 and 28:
acute graft-vs.-host reaction 12 ac
- Page 29 and 30:
acute lymphoblastic leukemia (ALL)
- Page 31 and 32:
acute poststreptococcal glomerulone
- Page 33 and 34:
acyclic adenosine monophosphate (cA
- Page 35 and 36:
adhesion receptors 20 adjuvant ICAM
- Page 37 and 38:
adoptive immunization 22 adoptive t
- Page 39 and 40:
afferent lymphatic vessels 24 agar
- Page 41 and 42:
agretope 26 AIDS belt exposure to c
- Page 43 and 44:
airway hyper-responsiveness 28 alka
- Page 45 and 46:
allergic contact dermatitis 30 allo
- Page 47 and 48:
allophonic mouse 32 allotype suppre
- Page 49 and 50:
alternative complement pathway 34 a
- Page 51 and 52:
ALVAC 36 aminoethylcarbazole (AEC)
- Page 53 and 54:
amphiregulin 38 amyloid P component
- Page 55 and 56:
anaphylactoid reaction 40 anaphylax
- Page 57 and 58:
aneuploidy 42 angioimmunoblastic ly
- Page 59 and 60:
ankylosing spondylitis 44 antibodie
- Page 61 and 62:
antibody-dependent cell-mediated cy
- Page 63 and 64:
antibody unit 48 anti-CD5 monoclona
- Page 65 and 66:
anti-Clq antibody 50 anti-double-st
- Page 67 and 68:
antigen-binding site 52 antigen pre
- Page 69 and 70:
antigen-presenting cell (APC) 54 an
- Page 71 and 72:
antigenic gain 56 antigenic peptide
- Page 73 and 74:
antiglial fibrillary acidic protein
- Page 75 and 76:
anti-human cytokeratin 7 antibody 6
- Page 77 and 78:
anti-human prostatic acid phosphata
- Page 79 and 80:
antimuscle actin primary antibody 6
- Page 81 and 82:
antinucleosome antibodies 66 antipa
- Page 83 and 84: antiprogesterone receptor antibody
- Page 85 and 86: antithymocyte globulin (ATG) 70 AP-
- Page 87 and 88: apoptosis 72 apoptosis Four caspase
- Page 89 and 90: apoptosis, caspase pathway 74 apopt
- Page 91 and 92: apoptosis, positive induction 76 ar
- Page 93 and 94: Arthus reaction 78 artificially acq
- Page 95 and 96: aspirin sensitivity reaction 80 ath
- Page 97 and 98: Auer rods 82 autoantibodies, virus
- Page 99 and 100: autochthonous 84 autogenous vaccine
- Page 101 and 102: autoimmune complement fixation reac
- Page 103 and 104: autoimmune uveoretinitis 88 avian i
- Page 105 and 106: avidity hypothesis 90 AZT Percent A
- Page 107 and 108: B7.2 costimulatory molecule 92 B ce
- Page 109 and 110: B cell coreceptor 94 B cell lymphop
- Page 111 and 112: B lymphocyte antigen receptor (BCR)
- Page 113 and 114: ackcross 98 bacterial immunity Euka
- Page 115 and 116: actericidin 100 BALB/c mice bacteri
- Page 117 and 118: asophil 102 Bcl-2 family A peripher
- Page 119 and 120: enign 104 bentonite (Al 2O 3·4SiO
- Page 121 and 122: β 1H 106 bifunctional antibodies
- Page 123 and 124: iotin-avidin system 108 bispecific
- Page 125 and 126: lood group antigens 110 BLR-1/MDR-1
- Page 127 and 128: ooster phenomenon 112 botulinum tox
- Page 129 and 130: equinar sodium (BQR) 114 Bretscher-
- Page 131 and 132: Brucella vaccine 116 bullous pemphi
- Page 133: ursa of Fabricius 118 butterfly ras
- Page 137 and 138: C1 inhibitor (C1 INH) deficiency 12
- Page 139 and 140: C2 deficiency 124 C3 deficiency ass
- Page 141 and 142: C3e 126 C4c C3e A C3c α chain nona
- Page 143 and 144: C7 (complement component 7) 128 C9
- Page 145 and 146: calcitonin 130 CALLA α β α β α
- Page 147 and 148: Canale-Smith syndrome 132 capping p
- Page 149 and 150: carbon clearance test 134 cardiac d
- Page 151 and 152: cartwheel nucleus 136 caspases Cart
- Page 153 and 154: catalytic antibody 138 CD1 eliminat
- Page 155 and 156: CD3 complex 140 CD4 η HOOC s s ZAP
- Page 157 and 158: CD8 molecule 142 CD15 D1 D2 D3 D4 C
- Page 159 and 160: CD21 144 CD23 C C C C C C C C C C C
- Page 161 and 162: CD33 146 CD42b aggregated immunoglo
- Page 163 and 164: CD46 148 CD55 CD46 An antigen that
- Page 165 and 166: CD72 150 CD92 homodimeric glycoprot
- Page 167 and 168: CD117 152 CD148 CD117 A 145-kDa ant
- Page 169 and 170: CD184 154 CD236 CD184 A 45-kDa anti
- Page 171 and 172: CD279 156 CD312 CD279 A 50- to 55-k
- Page 173 and 174: CDR 158 cell adhesion molecules (CA
- Page 175 and 176: cell surface immunoglobulin 160 cel
- Page 177 and 178: cerebrospinal fluid (CSF) immunoglo
- Page 179 and 180: chemoattractant 164 chemotactic fac
- Page 181 and 182: chief cell autoantibodies 166 chole
- Page 183 and 184: chromogranins 168 chronic active he
- Page 185 and 186:
chronic graft vasculopathy 170 chro
- Page 187 and 188:
chronic thyroiditis 172 cimetidine
- Page 189 and 190:
Claman, Henry 174 class I MHC molec
- Page 191 and 192:
class II region 176 class switching
- Page 193 and 194:
clathrin 178 clonal selection clath
- Page 195 and 196:
clotting system 180 coated vesicle
- Page 197 and 198:
Cogan’s syndrome 182 collagen Cog
- Page 199 and 200:
colon autoantibodies 184 combinatio
- Page 201 and 202:
common mucosal immune system (CMIS)
- Page 203 and 204:
complement deviation 188 complement
- Page 205 and 206:
complement receptor 4 (CR4) 190 com
- Page 207 and 208:
congenital agammaglobulinemia 192 c
- Page 209 and 210:
contact system 194 control SKIN con
- Page 211 and 212:
cooperation 196 corneal test Albert
- Page 213 and 214:
corticotrophin receptor antibodies
- Page 215 and 216:
CREG 200 Crohn’s disease polypept
- Page 217 and 218:
crossed immunoelectrophoresis 202 C
- Page 219 and 220:
cutaneous basophil hypersensitivity
- Page 221 and 222:
CYNAP antibodies 206 CYNAP antibodi
- Page 223 and 224:
cytokeratin 7 (K72), mouse 208 cyto
- Page 225 and 226:
cytokine synthesis inhibitory facto
- Page 227 and 228:
cytosolic aspartate-specific protea
- Page 230 and 231:
d-amino acid polymers Synthetic pep
- Page 232 and 233:
DAT 217 decay accelerating factor (
- Page 234 and 235:
delayed-type hypersensitivity (DTH)
- Page 236 and 237:
dendritic epidermal cell 221 dense
- Page 238 and 239:
dermatomyositis 223 designer antibo
- Page 240 and 241:
despecification 225 dextran with th
- Page 242 and 243:
diazo salt 227 differentiation Diap
- Page 244 and 245:
dinitrochlorobenzene (DNCB) 229 dip
- Page 246 and 247:
directional flow 231 disulfide bond
- Page 248 and 249:
DNA library 233 doctrine of origina
- Page 250 and 251:
double diffusion test 235 double-st
- Page 252 and 253:
drug-induced immune hemolytic anemi
- Page 254 and 255:
e allotype Rabbit immunoglobulin G
- Page 256 and 257:
echinoderms 241 ED 50 intestinal mu
- Page 258 and 259:
Ehrlich phenomenon (historical) 243
- Page 260 and 261:
elephantiasis 245 ENA antibodies St
- Page 262 and 263:
endogenous 247 endoplasmic reticulu
- Page 264 and 265:
endotoxin shock 249 envelope glycop
- Page 266 and 267:
eosinophil cationic protein (ECP) 2
- Page 268 and 269:
epithelial membrane antigen (EMA) 2
- Page 270 and 271:
erythroblastosis fetalis 255 estrog
- Page 272 and 273:
exotoxins 257 experimental autoimmu
- Page 274:
exudate 259 exudation immunoglobuli
- Page 277 and 278:
Fab′′ fragment 262 factor H The
- Page 279 and 280:
Fagraeus-Wallbom, Astrid Elsa (1913
- Page 281 and 282:
FasL/Fas cytotoxicity 266 Fc fragme
- Page 283 and 284:
Fc region 268 Fcγ receptors effect
- Page 285 and 286:
Felton phenomenon 270 fetus allogra
- Page 287 and 288:
fibrinogen 272 filarial immunity an
- Page 289 and 290:
FITC (fluorescein isothiocyanate) 2
- Page 291 and 292:
flocculation 276 flow cytometry ppt
- Page 293 and 294:
fluorescein-labeled antibody 278 fl
- Page 295 and 296:
fluorochrome 280 follicular hyperpl
- Page 297 and 298:
Foxp3 282 Francisella immunity whic
- Page 299 and 300:
functional antigen 284 fungi Dr. H.
- Page 302 and 303:
G protein Proteins that bind guanos
- Page 304 and 305:
gastrin-producing cell antibodies (
- Page 306 and 307:
gene family 291 genetic knockout en
- Page 308 and 309:
germ-free animal 293 Gershon, Richa
- Page 310 and 311:
glomerular basement membrane (GBM)
- Page 312 and 313:
GM 1 autoantibodies 297 gold therap
- Page 314 and 315:
GOR autoantibodies 299 Gowans, Jame
- Page 316 and 317:
graft arteriosclerosis 301 graft-vs
- Page 318 and 319:
granulocyte-macrophage colony-stimu
- Page 320:
gut-associated lymphoid tissue (GAL
- Page 323 and 324:
H chain disease 308 halothane antig
- Page 325 and 326:
hapten-carrier conjugate 310 Hashim
- Page 327 and 328:
HAT selection 312 HBx lymphocytes d
- Page 329 and 330:
heavy chain subclass 314 Helicobact
- Page 331 and 332:
hematopoietic cells 316 hemolysin m
- Page 333 and 334:
hemolytic system 318 hepatitis A (i
- Page 335 and 336:
hepatitis B virus protein X 320 hep
- Page 337 and 338:
herpes gestationis (HG) autoantibod
- Page 339 and 340:
heterophile antigen 324 high-dose t
- Page 341 and 342:
Hirszfeld, Ludwik (1884-1954) 326 h
- Page 343 and 344:
histocompatibility testing 328 Hist
- Page 345 and 346:
HIV-1 virus structure 330 HIV corec
- Page 347 and 348:
HLA-A 332 HLA-A, HLA-B, and HLA-C H
- Page 349 and 350:
HLA class II 334 HLA-DO Human class
- Page 351 and 352:
HLA-DR subregion 336 HLA tissue typ
- Page 353 and 354:
homing cell adhesion molecule (H-CA
- Page 355 and 356:
hookworm vaccine 340 HSC Hookworm v
- Page 357 and 358:
human SCID (hu-SCID) mouse 342 Hunt
- Page 359 and 360:
hybridoma 344 hyperacute graft reje
- Page 361 and 362:
hypereosinophilia 346 hypersensitiv
- Page 363 and 364:
hypogammaglobulinemia of infancy 34
- Page 365 and 366:
ICOS 350 idiotype network theory sp
- Page 367 and 368:
Igα/Igβ (CD79a/CD79b) 352 IgG sub
- Page 369 and 370:
IL5 354 immediate reaction IL5 Abbr
- Page 371 and 372:
immune costimulatory molecules 356
- Page 373 and 374:
immune neutropenia 358 immune respo
- Page 375 and 376:
immunization 360 immunobiology Hepa
- Page 377 and 378:
immunocytochemistry 362 immunodefic
- Page 379 and 380:
immunodeficiency with thrombocytope
- Page 381 and 382:
immunofluorescent “staining” of
- Page 383 and 384:
immunoglobulin α chain 368 immunog
- Page 385 and 386:
immunoglobulin evolution 370 immuno
- Page 387 and 388:
immunoglobulin gene superfamily 372
- Page 389 and 390:
immunoglobulin M (IgM) 374 immunogl
- Page 391 and 392:
immunoglobulin staining 376 immunog
- Page 393 and 394:
immunoincompetence 378 immunologic
- Page 395 and 396:
immunological escape 380 immunologi
- Page 397 and 398:
immunophilins (Tacrolimus and Rapam
- Page 399 and 400:
immunoscintigraphy 384 immunosurvei
- Page 401 and 402:
inbreeding 386 indirect staining sa
- Page 403 and 404:
infectious mononucleosis syndromes
- Page 405 and 406:
influenza virus immunity 390 influe
- Page 407 and 408:
innocent bystander 392 instructive
- Page 409 and 410:
insulin receptor autoantibodies 394
- Page 411 and 412:
interdigitating dendritic cell 396
- Page 413 and 414:
interfollicular region 398 interleu
- Page 415 and 416:
interleukin-1 Ra 400 interleukin-2
- Page 417 and 418:
interleukin-4 receptor (IL4R) 402 i
- Page 419 and 420:
interleukin-6 (IL6) 404 interleukin
- Page 421 and 422:
interleukin-8 (IL8; neutrophil-acti
- Page 423 and 424:
interleukin-10 (IL10) 408 interleuk
- Page 425 and 426:
interleukin-13 (IL13) 410 interleuk
- Page 427 and 428:
interleukin-18 (IL18) 412 interleuk
- Page 429 and 430:
interleukin-25 (IL25) 414 interleuk
- Page 431 and 432:
intraepidermal lymphocytes 416 Inv
- Page 433 and 434:
invasin 418 Ir genes of major histo
- Page 435 and 436:
islet cell transplantation 420 isoe
- Page 437 and 438:
isotype switching 422 IVIG 5' 5' V
- Page 439 and 440:
Japanese encephalitis virus vaccine
- Page 441 and 442:
Job’s syndrome 426 Jones-Mote rea
- Page 444 and 445:
K antigens Surface epitopes of Gram
- Page 446 and 447:
Kell blood group system 431 Ki auto
- Page 448 and 449:
kininases 433 Klebsiella immunity R
- Page 450 and 451:
Ku 435 Kunkel, Henry George (1916-1
- Page 452 and 453:
L + dose (historical) The smallest
- Page 454 and 455:
LAMP 1 and LAMP 2 439 Landsteiner,
- Page 456 and 457:
lapinized vaccine 441 latex particl
- Page 458 and 459:
lck, fyn, ZAP (phosphotyrosine kina
- Page 460 and 461:
lepromatous leprosy 445 leukapheres
- Page 462 and 463:
leukoagglutinin 447 leukocyte commo
- Page 464 and 465:
leukocytosis 449 leukotriene Leukoc
- Page 466 and 467:
Lewis blood group system 451 light
- Page 468 and 469:
light zone 453 linkage disequilibri
- Page 470 and 471:
linked recognition 455 linked recog
- Page 472 and 473:
Listeria monocytogenes 457 liver-ki
- Page 474 and 475:
long homologous repeat 459 LPS Stim
- Page 476 and 477:
lupus inhibitor 461 lymphadenopathy
- Page 478 and 479:
lymphoblast 463 lymphocyte Subcapsu
- Page 480 and 481:
lymphocyte antigen stimulation test
- Page 482 and 483:
lymphocytes, circulating (or recirc
- Page 484 and 485:
lymphokine 469 lysis Fabricius in b
- Page 486 and 487:
M13 bacteriophage An Escherichia co
- Page 488 and 489:
macrophage-activating factor (MAF)
- Page 490 and 491:
macrophage inflammatory protein 1β
- Page 492 and 493:
MAF 477 major histocompatibility co
- Page 494 and 495:
Mancini test 479 marsupial immunity
- Page 496 and 497:
mast cell tryptase 481 Masugi nephr
- Page 498 and 499:
maturation of affinity 483 Mcg isot
- Page 500 and 501:
mediastinal mass 485 Mediterranean
- Page 502 and 503:
membrane attack unit 487 membrane c
- Page 504 and 505:
memory 489 mercury and immunity dis
- Page 506 and 507:
methyl green pyronin stain 491 MHC
- Page 508 and 509:
MHD 493 microglobulin Class II MHC
- Page 510 and 511:
microtiter technique 495 MIG The se
- Page 512 and 513:
Milstein, Cesar (1927-) 497 MIP-1β
- Page 514 and 515:
mitogen 499 Mitsuda reaction mitoch
- Page 516 and 517:
mixed lymphocyte reaction (MLR) 501
- Page 518 and 519:
molecular hybridization probe 503 m
- Page 520 and 521:
monoclonal immunoglobulin 505 monoc
- Page 522 and 523:
monoclonal immunoglobulin depositio
- Page 524 and 525:
monomorphic 509 mononuclear cell IC
- Page 526 and 527:
Montagu, Lady Mary Wortley (1689-17
- Page 528 and 529:
mucosal tolerance 513 multilocus pr
- Page 530 and 531:
multiple sclerosis (MS) 515 mumps v
- Page 532 and 533:
myc 517 mycophenolate mofetil and a
- Page 534 and 535:
myelin basic protein (MBP) 519 myel
- Page 536:
myogenin (F5D, mouse) 521 myositis-
- Page 539 and 540:
natural antiviral immunity 524 natu
- Page 541 and 542:
naturally acquired immunity 526 Nei
- Page 543 and 544:
nephelometry 528 network theory VLA
- Page 545 and 546:
neuron-specific enolase (NSE) 530 n
- Page 547 and 548:
New Zealand white (NZW) mice 532 ni
- Page 549 and 550:
NON mouse 534 nonproductive rearran
- Page 551 and 552:
northern blotting 536 nuclear facto
- Page 553 and 554:
Nuttall, George H.F. (1862-1937) 53
- Page 555 and 556:
OKT4 540 oncofetal antigens OKT4 Re
- Page 557 and 558:
ontogeny 542 oral immunology ontoge
- Page 559 and 560:
orthotopic 544 Ouchterlony test Don
- Page 561 and 562:
Ovary, Zoltan 546 Owen, Ray David (
- Page 563 and 564:
oxygen-independent killing 548 Oz i
- Page 565 and 566:
panel reactive antibody (PRA) test
- Page 567 and 568:
papain 552 papain +H 3 N +H 3 N NH
- Page 569 and 570:
paradoxical reaction 554 paraprotei
- Page 571 and 572:
paroxysmal cold hemoglobinuria (PCH
- Page 573 and 574:
passive immunization 558 Pasteur, L
- Page 575 and 576:
pathogenesis-related (PR) proteins
- Page 577 and 578:
pemphigus vulgaris 562 pemphigus vu
- Page 579 and 580:
pepsinogen antibodies 564 peptidogl
- Page 581 and 582:
peripheral lymphoid tissues 566 per
- Page 583 and 584:
pFc′ fragment 568 phagocyte Plate
- Page 585 and 586:
phagocytosis 570 phagocytosis polym
- Page 587 and 588:
phosphatase 572 phytohemagglutinin
- Page 589 and 590:
pituitary hormones 574 plaque-formi
- Page 591 and 592:
plasmacyte 576 plasma pool Plasma c
- Page 593 and 594:
platelet-associated immunoglobulin
- Page 595 and 596:
poison ivy 580 polyacrylamide gel e
- Page 597 and 598:
polyclonal rabbit anti-calretinin 5
- Page 599 and 600:
polynucleotides 584 positive cross
- Page 601 and 602:
post-transfusion graft-vs.-host dis
- Page 603 and 604:
precipitating antibody 588 precipit
- Page 605 and 606:
precipitation reaction 590 presento
- Page 607 and 608:
primary follicle 592 primary struct
- Page 609 and 610:
privileged site 594 progressive sys
- Page 611 and 612:
ProPO system 596 prostate-specific
- Page 613 and 614:
proteasome genes 598 protein P prot
- Page 615 and 616:
protoplast fusion 600 pseudoallergi
- Page 617 and 618:
psychoneuroimmunology 602 purified
- Page 619 and 620:
pyroglobulins 604 pyroninophilic ce
- Page 621 and 622:
Quellung phenomenon 606 quinidine (
- Page 623 and 624:
adiation bone marrow chimeras 608 r
- Page 625 and 626:
adiomimetic drug 610 Raji cell assa
- Page 627 and 628:
Ras 612 Raynaud’s phenomenon H 3C
- Page 629 and 630:
eagin (historical) 614 recombinant
- Page 631 and 632:
egional enteritis 616 relapsing pol
- Page 633 and 634:
escue graft 618 resting lymphocytes
- Page 635 and 636:
eticuloendothelial blockade 620 ret
- Page 637 and 638:
everse transcriptase-polymerase cha
- Page 639 and 640:
hesus incompatibility 624 rheumatoi
- Page 641 and 642:
hinovirus immunity 626 ricin rhinov
- Page 643 and 644:
RNA polymerase (RNAP) I, II, and II
- Page 645 and 646:
osette 630 Roux, Emile (1853-1933)
- Page 648 and 649:
S Abbreviation for sedimentation co
- Page 650 and 651:
Sanarelli-Shwartzman reaction 635 s
- Page 652 and 653:
SCF (stem cell factor) 637 schistos
- Page 654 and 655:
scurfy mouse 639 secondary granule
- Page 656 and 657:
secretor 641 secretory immunoglobul
- Page 658 and 659:
selective IgM deficiency 643 select
- Page 660 and 661:
sensitization 645 sequence-specific
- Page 662 and 663:
serotherapy 647 serum hepatitis (he
- Page 664 and 665:
sex hormones and immunity 649 Séza
- Page 666 and 667:
Shwartzman (or Shwartzman-Sanarelli
- Page 668 and 669:
side effect 653 autoantibodies (SRP
- Page 670 and 671:
single diffusion test 655 single ra
- Page 672 and 673:
skin autoantibodies 657 skin immuni
- Page 674 and 675:
slp 659 Smith, Theobald (1859-1934)
- Page 676 and 677:
SOD 661 soluble complex DD TRADD FA
- Page 678 and 679:
specific immune response to extrace
- Page 680 and 681:
spliceosomal snRNP autoantibodies 6
- Page 682 and 683:
SS-A/Ro antibodies 667 stem cells S
- Page 684 and 685:
streptolysin O test 669 Strongyloid
- Page 686 and 687:
superinfection immunity 671 suppres
- Page 688 and 689:
S value (Svedberg unit) 673 switch
- Page 690 and 691:
synthetic polypeptide antigens 675
- Page 692:
systemic lupus erythematosus, anima
- Page 695 and 696:
tail peptide 680 Tamiflu® Gaspare
- Page 697 and 698:
TATA 682 T cell antigen receptors c
- Page 699 and 700:
T cell domains 684 T cell priming c
- Page 701 and 702:
T cell receptor a chain (TCRa) 686
- Page 703 and 704:
template theory (historical) 688 te
- Page 705 and 706:
tertiary response 690 tetanus toxin
- Page 707 and 708:
Th1/Th2 differentiation 692 T h0 ce
- Page 709 and 710:
theliolymphocyte 694 thorotrast (th
- Page 711 and 712:
thymectomy 696 thymic hormones and
- Page 713 and 714:
thymopentin (TP-5) 698 thymus 1 32
- Page 715 and 716:
thymus 700 thymus Hassall’s corpu
- Page 717 and 718:
thymus-dependent (TD) areas 702 thy
- Page 719 and 720:
thyrotoxicosis 704 tissue-specific
- Page 721 and 722:
TLR1-10 706 T lymphocyte (T cell) A
- Page 723 and 724:
TNF-related activation-induced cyto
- Page 725 and 726:
topoisomerase I 710 toxin neutraliz
- Page 727 and 728:
TRALI (transfusion-related acute lu
- Page 729 and 730:
transfusion 714 transfusion reactio
- Page 731 and 732:
translocation 716 trastuzumab trans
- Page 733 and 734:
triple vaccine 718 tuberculin halo
- Page 735 and 736:
tumor-associated antigens 720 tumor
- Page 737 and 738:
tumor necrosis factor β (TNF-β) 7
- Page 739 and 740:
tunicates 724 type I anaphylactic h
- Page 741 and 742:
type 1 diabetes mellitus (T1DM) 726
- Page 743 and 744:
type IV cell-mediated hypersensitiv
- Page 746 and 747:
U antigen A rare MNs erythrocyte an
- Page 748 and 749:
unidentified reading frame (URF) 73
- Page 750 and 751:
V28 An orphan chemokine receptor ex
- Page 752 and 753:
varicella (chickenpox) vaccine 737
- Page 754 and 755:
V(D)J recombinase 739 veno-occlusiv
- Page 756 and 757:
V gene segment 741 Vibrio cholerae
- Page 758 and 759:
viral immunity 743 vitamin A and im
- Page 760 and 761:
V(J) recombination 745 von Krough e
- Page 762 and 763:
w Symbol for workshop used for hist
- Page 764 and 765:
Weibel-Palade bodies 749 wheal-and-
- Page 766 and 767:
wire loop lesion 751 Wright, Almrot
- Page 768 and 769:
X cell See XYZ cell theory. X4 viru
- Page 770:
X-linked severe combined immunodefi
- Page 774 and 775:
ZAP-70 A T cell cytoplasmic tyrosin
- Page 776:
Zinkernagel, Rolf (1944-) and Doher
- Page 779 and 780:
I Appendix I 764 Mouse CD Chart Ant
- Page 781 and 782:
I Appendix I 766 Mouse CD Chart Ant
- Page 783 and 784:
I Appendix I 768 Mouse CD Chart Ant
- Page 785 and 786:
I Appendix I 770 Mouse CD Chart Ant
- Page 787 and 788:
I Appendix I 772 Mouse CD Chart Ant
- Page 789 and 790:
I Appendix I 774 Mouse CD Chart Ant
- Page 791 and 792:
I Appendix I 776 Mouse CD Chart Ant
- Page 793 and 794:
I Appendix I 778 Mouse CD Chart Ant
- Page 796 and 797:
Appendix III Cytokines and Their Re
- Page 798:
Appendix III 783 Cytokines and Thei
- Page 801 and 802:
IV Appendix IV 786 Chemokines and T
- Page 803 and 804:
V Appendix V 788 Human Leukocyte Di
- Page 805 and 806:
V Appendix V 790 Human Leukocyte Di
- Page 807 and 808:
V Appendix V 792 Human Leukocyte Di
- Page 809 and 810:
V Appendix V 794 Human Leukocyte Di
- Page 811 and 812:
V Appendix V 796 Human Leukocyte Di
- Page 813 and 814:
V Appendix V 798 Human Leukocyte Di
- Page 815 and 816:
V Appendix V 800 Human Leukocyte Di
- Page 818 and 819:
Dr. Robert C. Khayat Chancellor, Un